Company intelligence / Profile preview

neurocare group

Munich, Bavaria, Germanyneurocaregroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

neurocare’s integrated platform combines advanced neuromodulation devices (TMS, tDCS/tES), EEG/QEEG diagnostics, sleep assessment tools, and digital workflows to enable personalized mental healthcare. Clinical results highlight improved remission rates for depression when combining TMS with psychotherapy compared to standard treatments. The platform is deployed globally across owned clinics in Europe/Australia/US as well as partner sites.

Therapeutic areas: PsychiatryNeurology
Modalities: Device (Transcranial Magnetic Stimulation systems)Device (tDCS/tES stimulators)Device (Neurofeedback systems)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Impact Expansion (investor/partner)TVM Capital Healthcare (investor/partner)Third-party clinics worldwide

Beyond the preview

Go deeper on neurocare group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on neurocare group.

Explore the full profile